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A new electrospray ionization mass spectrometry (ES-MS) approach for quantifying protein–
ligand complexes that are prone to in-source (gas-phase) dissociation is described. The
method, referred to here as the reference ligand ES-MS method, is based on the direct ES-MS
assay and competitive ligand binding. A reference ligand (Lref), which binds specifically to the
protein (P), at the same binding site as the ligand (L) of interest, with known affinity and forms
a stable protein–ligand complex in the gas phase, is added to the solution. The fraction of P
bound to Lref, which is determined directly from the ES mass spectrum, is sensitive to the
fraction of P bound to L in solution and enables the affinity of P for L to be determined. A
mathematical framework for the implementation of the method in cases where P has one or
two specific ligand binding sites is given. Affinities of two carbohydrate-binding proteins, a
single chain fragment of a monoclonal antibody and the lectin concanavalin A, for monosac-
charide ligands are reported and the results are shown to agree with values obtained using
isothermal titration calorimetry. (J Am Soc Mass Spectrom 2010, 21, 1893–1899) © 2010
American Society for Mass SpectrometryThe direct electrospray ionization mass spectrom-etry (ES-MS) assay has emerged as a powerfultechnique for quantifying binding constants (Ka)
for protein–ligand interactions, as well as other nonco-
valent biological complexes, in solution [1–3]. The assay
is based on the direct detection and quantification of the
abundance (Ab) of ligand-bound and unbound protein
ions in the gas phase, e.g., PLn and Pn, respectively. A
key assumption is that the measured abundance ratio
(R) is equivalent to the equilibrium concentration ratio
of ligand-bound and free protein in solution, eq 1:
[PL]eq
[P]eq


n
Ab(PLn)

n
Ab(Pn)
R (1)
From the measured R value and initial concentrations of
protein ([P]o) and ligand ([L]o), Ka can be calculated, [4] eq 2:
Ka
R
[L]0
R
1R
[P]0
(2)
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doi:10.1016/j.jasms.2010.07.008The direct ES-MS assay has been used to measure
affinities for a range of protein–ligand complexes, in-
cluding antibody-antigen, lectin-carbohydrate, enzyme-
substrate/inhibitor complexes and, in many instances,
the Ka values agree well with constants obtained by
other analytical methods, including isothermal titration
calorimetry (ITC), surface plasmon resonance, and fron-
tal affinity chromatography MS [4–10]. However, there
have also been reports of protein–ligand complexes that
could not be detected by ES-MS or, if detected, the
relative abundance of ligand-bound and unbound pro-
tein ions did not match the distribution expected in
solution, with less binding observed in the gas phase
[11–14]. These anomalous results are often due the
occurrence of in-source dissociation, whereby the gas-
eous complexes undergo partial or complete dissocia-
tion during ES-MS analysis. If the gas-phase PL ions are
kinetically labile and undergo dissociation during anal-
ysis, the magnitude of the measured R value and,
correspondingly, the Ka value will be artificially low. In
the extreme case, where no PL ions survive, in-source
dissociation will result in a false negative. Recently, it
was shown that solution or gas-phase additives can, in
some instances, protect complexes from in-source dis-
sociation [12, 15]. However, this approach does have its
limitations and the detection of very labile gas-phase
complexes, which rapidly dissociate at ambient temper-
ature, by ES-MS remains problematic.
Here, we describe an indirect ES-MS approach to
quantify protein–ligand interactions that are highly
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referred to as the reference ligand ES-MS method,
employs direct ES-MS analysis in conjunction with a
reference ligand (Lref). The Lref binds specifically to P, at
the same binding site as L, with known affinity and
forms a stable protein–ligand complex in the gas phase.
The fraction of P bound to Lref, which is determined
directly from the ES mass spectrum, is sensitive to the
fraction of P bound to L in solution and enables the
affinity of the PL complex to be established. A mathe-
matical framework for the implementation of the
method in cases where P has one or two specific ligand
binding sites is given. To demonstrate the reliability of
the method, monosaccharide affinities were measured
for two carbohydrate-binding proteins, a single chain
fragment of a monoclonal antibody binding and the
lectin concanavalin A, and the values compared with
data obtained using ITC.
Experimental
Proteins and Ligands
The carbohydrate-binding antibody single chain frag-
ment, Se155-4 scFv (MW 26 539 Da), was produced
using recombinant technology [16]. The scFv was con-
centrated and dialyzed against aqueous solution of 50
mM ammonium acetate (pH 7) using microconcentra-
tors (Millipore Corp., Bedford, MA, USA) with a mo-
lecular weight cut-off of 10 kDa, and lyophilized before
MS analysis. The scFv was weighed immediately after
removing it from the lyophilizer, dissolved in a known
Figure 1. Influence of in-source dissociation on
complexes. (a) Hypothetical distribution of speci
with a single binding site of protein P. (b) In
abundance of gas-phase PLn and PLref
n ion
(c) In-source dissociation of the PLn ions (but
measured abundance ratio of PLref
n to Pn ions.volume of aqueous 50 mM ammonium acetate and
stored at 20 °C if not used immediately. The proteins
concanavalin A (ConA, MW 25 600 Da for monomer)
and lysozyme (Lyz, MW 14 311 Da) were purchased
from Sigma-Aldrich Canada (Oakville, Canada), and
used without further purification. The synthetic carbo-
hydrate ligands, abequose methyl glycoside (1), methyl
3-deoxyarabinose (2), methyl--D-glucopyranoside (3),
and Abe(2-OCH3-Man)GlcGlc (4) were provided
by Professor D. Bundle (University of Alberta), while
methyl--D-mannopyranoside (5) and -methyl-3,6-
di-O-(-D-mannopyranosyl)--D-mannopyranoside (6)
were purchased from Toronto Research Chemicals Inc
(North York, Canada).
Mass Spectrometry
All experiments were performed on an Apex II 9.4 tesla
Fourier transform ion cyclotron resonance (FT-ICR)
mass spectrometers (Bruker, Billerica, MA, USA)
equipped with an external nanoflow ES ion source. A
description of the instrument and the experimental and
instrumental parameters used in the ES-MS binding
measurements is given elsewhere [4].
Results and Discussion
Overview of Reference Ligand Method
The influence of in-source dissociation on ES-MS mass
spectra acquired for a solution of P and two ligands, L and
Lref, which bind at the same site, is depicted in Figure 1. In
relative abundance of gas-phase protein–ligand
sent in solution when ligands L and Lref interact
absence of in-source dissociation, the relative
ll reflect the original distribution in solution.
he PL n ions) will result in a decrease in thethe
es pre
the
s wi
not t ref
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uniform response factors and an absence of nonspecific
ligand binding), the measured abundance ratios of
ligand-bound to free P ions (R and Rref) will reflect the
concentration ratios in solution (Figure 1a and b) and Ka
for the PL complex can be calculated using eq 3:
Ka
R
[L]0
R
1RRref
[P]0
(3)
where R is given by eq 1 and Rref by eq 4:
[PLref]eq
[P]eq


n
Ab(PLref
n)

n
Ab(Pn)
Rref (4)
If, on the other hand, the gas-phase ions of the PL
complex are kinetically labile and undergo in-source
dissociation, the relative abundance of ligand-bound
and free protein ions measured by ES-MS will no longer
reflect the original concentration ratios (Figure 1a and
c). In the extreme case where no PL ions survive until
detection, the measured abundance ratio of Lref-bound
P to free P gas-phase ions (i.e., Rref,app) will depend on
the concentration of both free P and PL originally
present in solution, eq 5:
[PLref]eq
[P]eq [PL]eq


n
Ab(PLref
n)

n
Ab(Pn)
Rref, app (5)
However, if Ka,ref is known, Rref (the “true” concentra-
tion ratio [PLref]/[P]) can be calculated from Rref,app,
eq 6:
RrefKa,ref[Lref]o [P]o Rref, appRref, app 1 (6)
Furthermore, the magnitude of R can be calculated from
the corresponding Rref,app and Rref values, eq 7:
R
Rref
Rref, app
 1 (7)
Once R and Rref are known, the Ka value for the PL
complex can be calculated using eq 3.
It should be noted that the above treatment can
easily be extended to the case where the gas-phase PL
ions undergo partial dissociation in the source. In this
situation, Rref can be determined from the measured
abundance ratio of Lref-bound P to free P gas-phase ions
(i.e., Rref,app) and the measured abundance ratio of
L-bound P to free P gas-phase ions (i.e., Rapp) using eq 8:
RrefKa,ref[Lref]o [P]o Rref, appRref, appRapp 1 (8)
and R can be found using eq 9:R
(1Rapp)
Rref,app
Rref 1 (9)
Once R and Rref are known, Ka can be calculated in the
usual way.
Because many proteins possess multiple ligand bind-
ing sites, it is also useful to consider how the reference
ligand ES-MS method can be applied to these situations.
Given below are the relevant mathematical expressions
for the application of the method for the case where P
possesses two equivalent and independent ligand bind-
ing sites. Expressions for the equilibrium constants (Ka,1
and Ka,2) for the sequential binding of L to P in the
presence of Lref, written in terms of the concentration
ratios of ligand bound (L or Lref) P to free P, are:
Ka,1
R1,0
[L]o
R1,0 2R2,0R1,1[P]o
1R1,0R2,0R0,1R1,1R0,2
(10a)
Ka,2
R2,0
R1,0[L]o R1,0 2R2,0R1,1[P]o1R1,0R2,0R0,1R1,1R0,2
(10b)
where Ri,j is the concentration ratio of ligand-bound P
(to i molecules of L and j molecules of Lref) to free P. As
before, in the absence of in-source dissociation, the Ri,j
values can be determined directly from the relative
abundance of ligand-bound and free P ions measured
by ES-MS, eq 11:
[P(L)i(Lref)j]eq
[P]eq


n
Ab(PLiLref,j
n)

n
Ab(Pn)
Ri,j (11)
However, if in-source dissociation takes place, the mea-
sured ratios will no longer reflect solution composition.
In the extreme case, where none of the P-L interactions
survive the ion source, only the ratios R0,1app and R0,2app
can be determined from the ES mass spectrum:

n
Ab(PLref
n)

n
Ab(Pn)
R0,1app (12a)

n
Ab(P(Lref)2
n)

n
Ab(Pn)
R0,2app (12b)
Using the known values of Ka1,Lref, [Lref]o, [P]o, R0,1app
and R0,2app, the Ri,j terms can be calculated using follow-
ing expressions:
R0,1app 2R0,2app
R0,1Ka1,Lref[Lref]0 [P]0 1R0,1appR0,2app (13a)
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2 ⁄ 4 (13b)
R1,1
R0,1app R0,2
R0,2app
R0,1 (13c)
R1,02 2 R0,2R0,2app (13d)
R2,0 1
R0,2
R0,2app
 2 R0,2R0,2app (13e)
and Ka,1 and Ka,2 can be calculated using eqs 10a and
10b.
The two basic requirements for a suitable Lref are that
it binds specifically to P in solution, at the same binding
site as L, with a known affinity and that it forms a stable
protein-ligand interaction in the gas phase, i.e., is resis-
tant to in-source dissociation. In addition, there are
several other practical considerations. It is desirable to
use a reasonably strong binding ligand as Lref, with a
Ka,ref of 10
5–107 M1, since in this case Rref and Rref,app
are more sensitive to the presence of the competing
ligand. Additionally, changes in Rref are more pro-
nounced when low protein concentrations (M) are
used. Finally, depending on the magnitude of Ka and
Ka,ref, the concentrations of P and both ligands (L and
Lref) may need to be adjusted so that both complexes are
present in solution at significant concentrations.
Determination of Protein–Ligand Affinities
To demonstrate the reliability of the reference ligand
ES-MS method for quantifying protein–ligand interac-
tions that are not readily detected by ES-MS, binding
measurements were carried out on two carbohydrate-
binding proteins, Se155-4 scFv and ConA. Association
constants have been determined by ITC for the binding
of Se155-4 scFv to the monosaccharides 1 (1.5  103
M1) and 2 (1.2  102 M1) at pH 7 and 25 °C [17]. The
monosaccharide 3, which was shown by ITC not to bind
to the scFv [Bundle, D.R., Unpublished results], served
as a negative control. Con A is a tetramer above pH 7
and a dimer below pH 6. Each subunit possesses a
single carbohydrate binding site with specificity for the
-pyranose forms of Glc or Man. The affinity of dimeric
ConA for the monosaccharide 5 was determined to be
(7.9  1.0)  103 M1 at pH 5.2 and 25°C by ITC [18].
scFv-Monosaccharide Binding
Shown in Figure 2a is a representative ES mass spec-
trum acquired for a solution of scFv (10 M) and 1 (1
mM) at pH 7 and 25 °C. A reference protein (Lyz) was
also added to monitor for the occurrence of non-specific
ligand binding to scFv during the ES process [19]. At
these concentrations, 60% of the scFv is expected to be
bound to 1 in solution. However, no gas-phase ionscorresponding to the specific (scFv  1) complex were
detected, indicating the occurrence of in-source disso-
ciation. Attempts to stabilize the complex during ES-MS
analysis using a high concentration (10 mM) of imida-
zole, a stabilizing additive [12], were unsuccessful (data
not shown). The instability of the gas-phase ions of the
(scFv  1) complex can be explained by the small
number of intermolecular hydrogen bonds that 1 is
capable of making. Direct ES-MS analysis of solutions of
scFv (10 M) with 2 (2 mM) or 3 (1 mM) also failed to
detect ions of the (scFv 2) or (scFv 3) complex (data
not shown). In contrast, ES-MS analysis of a solution of
scFv (10 M) and 4 (59 M) clearly identified the
presence of gas-phase ions corresponding to the (scFv
4) complex, Figure 2b. The Ka value determined directly
from the ES mass spectrum, following correction for
nonspecific ligand binding [19], was (1.6  0.5)  105
M1. Shown in Figure 2c is a representative ES mass
spectrum acquired for a solution of scFv (10 M), 1 (1
mM) and 4 (59 M). Although ions corresponding to
the (scFv  1) complex were not detected, the addition
of 1 to the solution resulted in a decrease in the fraction
of scFv bound to 4, indicating the presence of specific
binding between scFv and 1 in solution. Plotted in
Figure 3 is the fraction of bound (to 4) and unbound
scFv determined by direct ES-MS measurements at
fixed concentrations of scFv (10 M) and 4 (59 M) and
varying concentrations of 1 (0, 500, 1000, and 2000 M).
Notably, the fraction of scFv bound to 4 decreased with
increasing concentration of 1. Analysis of the ES-MS
data using the approach described above leads to an
average Ka value of (1.4  0.3)  10
3 M1 for the (scFv 
1) complex, Table 1. This value is indistinguishable,
within experimental error, from the ITC-derived value of
(1.5  0.4)  103 M1 [17]. Following the same approach,
a Ka value of (1.7 0.9) 10
2 M1 was determined for the
(scFv 2) complex, which is also in good agreement with
the ITC value of (1.2 0.5) 102 M1 [17]. In contrast, the
assay did not detect any binding between the scFv and 3,
consistent with the results of ITC measurements [Bundle,
D.R., Unpublished results].
ConA-Monosaccharide Binding
To demonstrate that the reference ligand ES-MS method
is generally applicable to the quantification of labile
protein–ligand interactions, the method was also used
to measure the affinity of the lectin ConA for the
monosaccharide 5. The binding measurements were
performed at pH 5.2, where ConA exists predominantly
as a homodimer. At this pH, ConA is known to bind the
monosaccharide 5, as well as oligomannose ligands
such as 6, which served as Lref for these measurements
[20]. Importantly, it was previously shown that 5 and 6
bind in the same binding site [21]. In an earlier study, it
was reported that the ConA–5 interaction is quite labile
in the gas phase and can be, depending on the ES-MS
instrumentation used, difficult to detect [11]. In the
present work, it was found that the complex could be
1897J Am Soc Mass Spectrom 2010, 21, 1893–1899 QUANTIFYING LABILE PROTEIN–LIGAND COMPLEXESdirectly detected by ES-MS. However, the relative
abundance of the ligand-bound forms of ConA dimer
was sensitive to ion source conditions, such as hexapole
accumulation time. To demonstrate the reliability of the
assay in cases where the complex could not be directly
detected, source conditions that lead to complete disso-
ciation of the ConA-5 interactions were used.
Figure 2. ES mass spectra obtained for the solu
4 (59 M), and (c) 4 (59 M) and 1 (1000 M). Th
is indicated by q.
Figure 3. Distribution of the relative abundance of scFv ( P)
and (scFv 4) complex ( PLref) measured by ES-MS for solutions
of scFv (10 M), 4 (59 M), and 1 at concentrations of 0, 500, 1000,
and 2000 M.Shown in Figure 4a is an ES mass spectrum mea-
sured for a solution of ConA (30 M for monomer) at
pH 5.2. Notably, only ions corresponding to ConA
homodimer (ConA2) were identified; no ions corre-
sponding to monomer or homotetramer were detected.
Upon addition of 6 (15 M) to the solution, ions
corresponding to ConA2 bound to one and two mole-
cules of 6 were also detected (Figure 4b). The intrinsic
affinity of ConA2 for 6, based on the Ka,1 and Ka,2 values
determined directly from the ES mass spectra, is (5 
2)  105 M1. This value is in excellent agreement with
Table 1. Association constants (Ka) for carbohydrate ligand
binding to Se155-4 scFv and ConA determined by the ES-MS
reference ligand method and by ITC at 25°Ca
Protein Ligand pH
ES-MS Ka 
10–3 (M–1)
ITC Ka 
10–3 (M–1)
scFv 1 7.0 1.4  0.3 1.5  0.4b
scFv 2 7.0 0.17  0.09 0.12  0.05b
scFv 3 7.0 NBc NBc
ConA 5 5.2 10  4d 7.9  1.0d,e
aErrors correspond to one standard deviation.
bValues taken from reference [16].
cNB  No binding detected.
d
of Se155-4 scFv (10 M) and (a) 1 (1000 M), (b)
ber of molecules of 4 bound to the protein ionstions
e numValues correspond to average intrinsic Ka for dimeric ConA.
eValue taken from reference [18].
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ITC for homodimer of ConA at pH 5.2 [20]. Under the
experimental conditions used, ES-MS analysis of a
solution of ConA2 (13 M) with 5 (50 or 100 M) and 6
(15 M) led to the detection of ions corresponding to
ConA2 bound to one and two molecules of 6 but not
ions corresponding to ConA2 bound to 5 (Figure 4c).
However, the addition of 5 to the solution did result in
a small but measurable reduction in the fraction of
ConA2 bound to 6. Following the procedures outlined
above, the intrinsic Ka for the ConA2–5 interaction was
determined to be (1.0  0.4)  104 M1, which is in
reasonable agreement with the ITC-derived value of
(7.9  1.0)  103 M1 [18], Table 1.
Conclusions
In summary, an ES-MS approach for quantifying
protein–ligand interactions that are prone to in-source
dissociation and, therefore, difficult to detect directly is
described. The reference ligand ES-MS method employs
the direct ES-MS assay in conjunction with a Lref, which
binds competitively to protein of interest with known
affinity and forms a stable complex in the gas-phase.
Figure 4. ES mass spectra obtained for the solu
M), and (c) 6 (15 M) and 5 (100 M). The nu
indicated by q.The relative abundance of Lref-bound protein to freeprotein, which can be measured directly by ES-MS, is
sensitive to the presence of other ligands in solution
that compete for the same binding site. As a result, it is
possible to quantify protein–ligand interactions that are
unstable in the gas-phase by measuring the relative
abundance of Lref-bound protein using the direct ES-MS
assay. The relevant mathematical expressions for the
implementation of the method for proteins with a sin-
gle ligand binding site or two equivalent binding sites are
given. To demonstrate the reliability of the method, the
binding of monosaccharide ligands to two carbohydrate-
binding proteins was quantified. Importantly, the carbo-
hydrate affinities were found to be in good agreement
with values measured using ITC. It is anticipated that this
method will prove particularly useful in extending the
application of ES-MS binding measurements to protein
interactions with small or hydrophobic ligands and for
implementing a small fragment approach to the elucidat-
ing details of protein–oligosaccharide interactions [22].
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